Evidence map›Paper›PMID 37529952›Full record

ArticleZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics2023

[Value of serum fibroblast growth factor 23 in diagnosis of hypophosphatemic rickets in children].

Sha-Sha Dong, Ruo-Chen Che, Bi-Xia Zheng, Ai-Hua Zhang, Chun-Li Wang, Mi Bai, Ying Chen

Open access · greenAbstract readEnglish Abstract
In one paragraph

Article in Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Sha-Sha DongDepartment of Nephrology, Children's Hospital of Nanjing Medical University, Nanjing 210000, China.
Ruo-Chen CheDepartment of Nephrology, Children's Hospital of Nanjing Medical University, Nanjing 210000, China.
Bi-Xia Zheng
Ai-Hua ZhangDepartment of Nephrology, Children's Hospital of Nanjing Medical University, Nanjing 210000, China.
Chun-Li Wang
Mi Bai
Ying ChenDepartment of Nephrology, Children's Hospital of Nanjing Medical University, Nanjing 210000, China.
Nanjing Children's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo study the value of serum fibroblast growth factor 23 (FGF23) in the diagnosis of hypophosphatemic rickets in children.

methodsA total of 28 children who were diagnosed with hypophosphatemic rickets in Children's Hospital of Nanjing Medical University from January 2016 to June 2021 were included as the rickets group. Forty healthy children, matched for sex and age, who attended the Department of Child Healthcare of the hospital were included as the healthy control group. The serum level of FGF23 was compared between the two groups, and the correlations of the serum FGF23 level with clinical characteristics and laboratory test results were analyzed. The value of serum FGF23 in the diagnosis of hypophosphatemic rickets was assessed.

resultsThe rickets group had a significantly higher serum level of FGF23 than the healthy control group (

conclusionsSerum FGF23 is of valuable in the diagnosis of hypophosphatemic rickets in children, which providing a theoretical basis for early diagnosis of this disease in clinical practice.

Indexed as

Familial Hypophosphatemic RicketsRickets, HypophosphatemicChildFibroblast Growth Factor-23Fibroblast Growth FactorsHumansFibroblast Growth Factor-23Fibroblast Growth FactorsChildEarly diagnosisFibroblast growth factor 23Hypophosphatemic ricketsPHEX gene

Identifiers

PMID37529952
PMCPMC10414175
OpenAlexW4385476871

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.